Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.

Sajdyk TJ, Boyle FA, Foran KS, Tong Y, Pandya P, Smith EML, Ho RH, Wells E, Renbarger JL.

J Pediatr Hematol Oncol. 2019 Oct 18. doi: 10.1097/MPH.0000000000001604. [Epub ahead of print]

PMID:
31634238
2.

Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.

Li L, Sajdyk T, Smith EML, Chang CW, Li C, Ho RH, Hutchinson R, Wells E, Skiles JL, Winick N, Martin PL, Renbarger JL.

Clin Pharmacol Ther. 2019 Jun;105(6):1421-1428. doi: 10.1002/cpt.1324. Epub 2019 Jan 21.

PMID:
30506673
3.

CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.

Skiles JL, Chiang C, Li CH, Martin S, Smith EL, Olbara G, Jones DR, Vik TA, Mostert S, Abbink F, Kaspers GJ, Li L, Njuguna F, Sajdyk TJ, Renbarger JL.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26854. Epub 2017 Nov 8.

4.

Project development teams: a novel mechanism for accelerating translational research.

Sajdyk TJ, Sors TG, Hunt JD, Murray ME, Deford ME, Shekhar A, Denne SC.

Acad Med. 2015 Jan;90(1):40-6. doi: 10.1097/ACM.0000000000000528.

5.

Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic.

Johnson PL, Sajdyk TJ, Fitz SD, Hale MW, Lowry CA, Hay-Schmidt A, Shekhar A.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:248-56. doi: 10.1016/j.pnpbp.2013.02.014. Epub 2013 Mar 21.

6.

NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons.

Molosh AI, Sajdyk TJ, Truitt WA, Zhu W, Oxford GS, Shekhar A.

Neuropsychopharmacology. 2013 Jun;38(7):1352-64. doi: 10.1038/npp.2013.33. Epub 2013 Jan 28.

7.

Cell-specific expression of calcineurin immunoreactivity within the rat basolateral amygdala complex and colocalization with the neuropeptide Y Y1 receptor.

Leitermann RJ, Sajdyk TJ, Urban JH.

J Chem Neuroanat. 2012 Oct;45(1-2):50-6. doi: 10.1016/j.jchemneu.2012.07.005. Epub 2012 Aug 4.

PMID:
22884996
9.

Measurement of panic-like responses following intravenous infusion of sodium lactate in panic-prone rats.

Sajdyk TJ, Keim SR, Thielen SR, Fitz SD, Shekhar A.

Curr Protoc Neurosci. 2003 Nov;Chapter 9:Unit 9.17. doi: 10.1002/0471142301.ns0917s24.

PMID:
18428590
10.

Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior.

Sajdyk T, Johnson P, Fitz S, Shekhar A.

J Psychopharmacol. 2008 Aug;22(6):633-41. doi: 10.1177/0269881107082902. Epub 2008 Feb 28.

11.

Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia.

Sajdyk TJ, Johnson PL, Leitermann RJ, Fitz SD, Dietrich A, Morin M, Gehlert DR, Urban JH, Shekhar A.

J Neurosci. 2008 Jan 23;28(4):893-903. doi: 10.1523/JNEUROSCI.0659-07.2008.

12.

Neonatal amygdala lesions: co-occurring impact on social/fear-related behavior and cocaine sensitization in adult rats.

Chambers RA, Sajdyk TJ, Conroy SK, Lafuze JE, Fitz SD, Shekhar A.

Behav Neurosci. 2007 Dec;121(6):1316-27.

13.

From anxiety to autism: spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats.

Truitt WA, Sajdyk TJ, Dietrich AD, Oberlin B, McDougle CJ, Shekhar A.

Psychopharmacology (Berl). 2007 Mar;191(1):107-18. Epub 2007 Feb 3.

PMID:
17277936
14.

Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus.

Shekhar A, Johnson PL, Sajdyk TJ, Fitz SD, Keim SR, Kelley PE, Gehlert DR, DiMicco JA.

J Neurosci. 2006 Sep 6;26(36):9205-15.

16.

Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety.

Shekhar A, Truitt W, Rainnie D, Sajdyk T.

Stress. 2005 Dec;8(4):209-19. Review.

PMID:
16423710
17.

Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.

Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, Shaw J, Fitz SD, Sajdyk TJ.

Eur J Pharmacol. 2005 Feb 21;509(2-3):145-53.

PMID:
15733549
18.

Interactions between NPY and CRF in the amygdala to regulate emotionality.

Sajdyk TJ, Shekhar A, Gehlert DR.

Neuropeptides. 2004 Aug;38(4):225-34. Review.

PMID:
15337374
19.

Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders.

Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A.

J Neurosci. 2004 Apr 7;24(14):3471-9.

20.

The amygdala, panic disorder, and cardiovascular responses.

Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG.

Ann N Y Acad Sci. 2003 Apr;985:308-25. Review.

PMID:
12724167
21.

Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats.

Sajdyk TJ, Schober DA, Gehlert DR.

Neuropharmacology. 2002 Dec;43(7):1165-72.

PMID:
12504923
22.

Role of norepinephrine in the dorsomedial hypothalamic panic response: an in vivo microdialysis study.

Shekhar A, Katner JS, Sajdyk TJ, Kohl RR.

Pharmacol Biochem Behav. 2002 Mar;71(3):493-500.

PMID:
11830183
23.

Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala.

Sajdyk TJ, Schober DA, Smiley DL, Gehlert DR.

Pharmacol Biochem Behav. 2002 Mar;71(3):419-23.

PMID:
11830176
25.

Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala.

Sajdyk TJ, Shekhar A.

Eur J Pharmacol. 2000 Apr 14;394(2-3):265-73.

PMID:
10771292
26.

Acoustic startle and fear-potentiated startle in alcohol-preferring (P) and -nonpreferring (NP) lines of rats.

Mckinzie DL, Sajdyk TJ, Mcbride WJ, Murphy JM, Lumeng L, Li TK, Shekhar A.

Pharmacol Biochem Behav. 2000 Apr;65(4):691-6.

PMID:
10764924
27.

Role of the basolateral amygdala in panic disorder.

Shekhar A, Sajdyk TS, Keim SR, Yoder KK, Sanders SK.

Ann N Y Acad Sci. 1999 Jun 29;877:747-50. No abstract available.

PMID:
10415697
28.

Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses.

Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A.

Behav Brain Res. 1999 Apr;100(1-2):207-15.

PMID:
10212068
29.

Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test.

Sajdyk TJ, Vandergriff MG, Gehlert DR.

Eur J Pharmacol. 1999 Mar 5;368(2-3):143-7.

PMID:
10193650
31.
32.

Monoamines in the dorsomedial hypothalamus of rats following exposure to different tests of "anxiety".

Sajdyk TJ, Katner JS, Shekhar A.

Prog Neuropsychopharmacol Biol Psychiatry. 1997 Jan;21(1):193-209.

PMID:
9075267
33.

Fear-potentiated startle elevates catecholamine levels in the dorsomedial hypothalamus of rats.

Shekhar A, Katner JS, Rusche WP, Sajdyk TJ, Simon JR.

Pharmacol Biochem Behav. 1994 Jun;48(2):525-9.

PMID:
8090826

Supplemental Content

Loading ...
Support Center